Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery
- PMID: 15488797
- DOI: 10.1016/j.ajo.2004.05.033
Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery
Abstract
Aim: To study the effects of intracameral injection of triamcinolone acetonide on visualizing and removing the vitreous body from the anterior chamber in cataract surgery.
Design: Observational case series.
Methods: Six eyes of six patients had the posterior capsule ruptured and the vitreous body prolapsed or incarcerated into the anterior chamber during cataract surgery. To visualize vitreous body, triamcinolone acetonide solution was injected into the anterior chamber and the vitreous body was resected. The intraoperative findings, results, and complications were evaluated.
Results: Vitreous body was well observed under surgical microscopy and was resected safely and completely. Minimum inflammation was observed postoperatively, and the patients obtained good visual acuity. No serious complications were found. One eye showed increased intraocular pressure (40 mm Hg), which was normalized by additional washing of the anterior chamber.
Conclusions: Appropriate use of intracameral triamcinolone acetonide is beneficial to visualize and remove the vitreous body from the anterior chamber during cataract surgery, and sufficient washing of the anterior chamber is necessary to avoid complications.
Comment in
-
Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.Am J Ophthalmol. 2005 Apr;139(4):756; author reply 756. doi: 10.1016/j.ajo.2004.11.058. Am J Ophthalmol. 2005. PMID: 15808207 No abstract available.
Similar articles
-
Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery.Am J Ophthalmol. 2005 Apr;139(4):756; author reply 756. doi: 10.1016/j.ajo.2004.11.058. Am J Ophthalmol. 2005. PMID: 15808207 No abstract available.
-
Experimental use of estriol for visualizing the vitreous body in the anterior chamber after posterior capsule rupture in animal models.J Cataract Refract Surg. 2009 Jul;35(7):1260-5. doi: 10.1016/j.jcrs.2009.02.022. J Cataract Refract Surg. 2009. PMID: 19545818
-
Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.Acta Ophthalmol. 2008 Feb;86(1):97-102. doi: 10.1111/j.1600-0420.2007.01058.x. Epub 2007 Oct 1. Acta Ophthalmol. 2008. PMID: 17908254
-
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x. Acta Ophthalmol Scand. 2005. PMID: 16396641 Review.
-
Management of vitreous loss and dropped nucleus during cataract surgery.Ophthalmol Clin North Am. 2006 Dec;19(4):495-506. doi: 10.1016/j.ohc.2006.07.002. Ophthalmol Clin North Am. 2006. PMID: 17067904 Review.
Cited by
-
Visualizing vitreous in vitrectomy by triamcinolone.Graefes Arch Clin Exp Ophthalmol. 2009 Sep;247(9):1153-63. doi: 10.1007/s00417-009-1118-2. Epub 2009 Jun 20. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19543906 Review.
-
Posterior capsular rent: Prevention and management.Indian J Ophthalmol. 2017 Dec;65(12):1359-1369. doi: 10.4103/ijo.IJO_1057_17. Indian J Ophthalmol. 2017. PMID: 29208816 Free PMC article. Review.
-
The visualisation of vitreous using surface modified poly(lactic-co-glycolic acid) microparticles.Br J Ophthalmol. 2010 May;94(5):648-53. doi: 10.1136/bjo.2009.163642. Br J Ophthalmol. 2010. PMID: 20447968 Free PMC article.
-
Glaucoma and retained-triamcinolone in pediatric cataract surgery.Eye (Lond). 2016 Sep;30(9):1273-4. doi: 10.1038/eye.2016.117. Epub 2016 Jun 10. Eye (Lond). 2016. PMID: 27285325 Free PMC article. No abstract available.
-
Efficacy of intracameral preservative-free triamcinolone acetonide in pediatric cataract surgery: a meta-analysis.Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2205-2212. doi: 10.1007/s00417-020-04765-x. Epub 2020 Jun 12. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32533281
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical